Akiyama M, Kaneko Y. (2022) Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Autoimmun Rev 21.
Al Barashdi MA, Ali A, McMullin MF, Mills K. Protein tyrosine phosphatase receptor type C (PTPRC or CD45). J Clin Pathol. 2021;74:548–52. https://doi.org/10.1136/jclinpath-2020-206927.
Article CAS PubMed Google Scholar
Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320:1360–72.
Augusto Silva dos Santos, Rodrigues P, Lima de Oliveira A, Mattos Brandão K, et al. Genetic variants in the TNF pathway impact TNFi response in a mixed population with rheumatoid arthritis. Gene. 2024;928. https://doi.org/10.1016/j.gene.2024.148804.
Beltrán Ramírez O, Mendoza Rincón JF, Barbosa Cobos RE, et al. STAT4 confers risk for rheumatoid arthritis and systemic lupus erythematosus in Mexican patients. Immunol Lett. 2016;175:40–3. https://doi.org/10.1016/j.imlet.2016.05.003.
Article CAS PubMed Google Scholar
Conigliaro P, Ciccacci C, Politi C. Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis. PLoS ONE. 2017. https://doi.org/10.1371/journal.pone.0169956.
Article PubMed PubMed Central Google Scholar
Daha NA, Kurreeman FAS, Marques RB, et al. Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis. Arthritis Rheum. 2009;60:1255–60. https://doi.org/10.1002/art.24503.
Daïen CI, Fabre S, Rittore C, et al. TGF beta1 polymorphisms are candidate predictors of the clinical response to rituximab in rheumatoid arthritis. Joint Bone Spine. 2012;79:471–5. https://doi.org/10.1016/j.jbspin.2011.10.007.
Article CAS PubMed Google Scholar
de Araújo JLF, de Almeida IM, Azevedo SB, et al. Association of PTPRC gene polymorphisms with TNF inhibitor efficacy in rheumatoid arthritis: a systematic review and meta-analysis. J Transl Genet Genomics. 2025;9:304–13. https://doi.org/10.20517/jtgg.2025.70.
Do H-T, Baars W, Borns K, et al. The 77 C→G mutation in the human CD45 (PTPRC) gene leads to increased intensity of TCR signaling in T cell lines from healthy individuals and patients with multiple sclerosis. J Immunol. 2006;176:931–8. https://doi.org/10.4049/jimmunol.176.2.931.
Article CAS PubMed Google Scholar
El-Lebedy D, Raslan H, Ibrahim A, et al. Association of STAT4 rs7574865 and PTPN22 rs2476601 polymorphisms with rheumatoid arthritis and non-systemically reacting antibodies in Egyptian patients. Clin Rheumatol. 2017;36:1981–7. https://doi.org/10.1007/s10067-017-3632-7.
El-Saadany HM, Amer WH, Khalil HS, et al. Association of STAT4 polymorphism with susceptibility and severity of rheumatoid arthritis and systemic lupus erythematosus in Egyptian patients. Egypt Rheumatol. 2016;38:21–7. https://doi.org/10.1016/j.ejr.2015.04.003.
Elshazli R, Settin A. Association of PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with rheumatoid arthritis: a meta-analysis update. Immunobiology. 2015;220:1012–24. https://doi.org/10.1016/j.imbio.2015.04.003.
Article CAS PubMed Google Scholar
Eskelinen ASA, Tanska P, Florea C, et al. Mechanobiological model for simulation of injured cartilage degradation via Proinflammatory cytokines and mechanical. PLoS Comput Biol. 2020;16. https://doi.org/10.1371/journal.pcbi.1007998
Ferreiro-Iglesias A, Montes A, Perez-Pampin E, et al. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis. Pharmacogenomics J. 2016;16:137–40. https://doi.org/10.1038/tpj.2015.29.
Article CAS PubMed Google Scholar
Furqan M, Mukhi N, Lee B, Liu D. Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application. Biomarker Res. 2013. https://doi.org/10.1186/2050-7771-1-5.
Gao W, Dong X, Yang Z, et al. Association between rs7574865 polymorphism in STAT4 gene and rheumatoid arthritis: an updated meta-analysis. Eur J Intern Med. 2020;71:101–3.
Ghanavati F, Nezhad SRK, Hajjari MR, Akhoond MR. Association of signal transducer and activator of transcription 4 rs10181656 polymorphism with rheumatoid arthritis and systemic sclerosis in Khuzestan Province in Southwestern Iran. Arch Rheumatol. 2019;34:434–42. https://doi.org/10.5606/ArchRheumatol.2019.7376.
Article PubMed PubMed Central Google Scholar
González JR, Armengol L, Solé X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics. 2007;23:644–5. https://doi.org/10.1093/bioinformatics/btm025.
Lee YH, Bae SC, Song GG. Meta-analysis of associations between functional HLA-G polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int. 2015;35:953–61.
Article CAS PubMed Google Scholar
Lin YJ, Anzaghe M, Schülke S. (2020) Update on the Pathomechanism, Diagnosis, and treatment options for rheumatoid arthritis. Cells 9.
Little J, Higgins JPT, Ioannidis JPA, et al. Strengthening the reporting of genetic association studies (STREGA)- an extension of the STROBE statement. Genet Epidemiol. 2009;33:581–98. https://doi.org/10.1002/gepi.20410.
Nageeb RS, Omran AA, Nageeb GS, et al. STAT4 gene polymorphism in two major autoimmune diseases (multiple sclerosis and juvenile onset systemic lupus erythematosus) and its relation to disease severity. Egypt J Neurol Psychiatry Neurosurg. 2018. https://doi.org/10.1186/s41983-018-0011-5.
Padyukov L. Genetics of rheumatoid arthritis. Semin Immunopathol. 2022;44:47–62.
Article CAS PubMed PubMed Central Google Scholar
Plant D, Prajapati R, Hyrich KL. Replication of association of the PTPRC gene with response to anti–tumor necrosis factor therapy in a large UK cohort. Arthritis Rheum. 2012;64:665–70. https://doi.org/10.1002/art.33381.
Article CAS PubMed PubMed Central Google Scholar
Potter DM. A permutation test for inference in logistic regression with small- and moderate-sized data sets. Stat Med. 2005;24:693–708. https://doi.org/10.1002/sim.1931.
Qi X, Li F, Zhang Y, et al. STAT4 genetic polymorphism significantly affected HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients receiving Peginterferon-α therapy: a prospective cohort study in China. J Med Virol. 2022;94(9):4449–58. https://doi.org/10.1002/jmv.27880.
Article CAS PubMed Google Scholar
Rönnelid J, Turesson C, Kastbom A. Autoantibodies in rheumatoid arthritis – laboratory and clinical perspectives. Front Immunol. 2021. https://doi.org/10.3389/fimmu.2021.685312.
Article PubMed PubMed Central Google Scholar
Rose-John S. The soluble interleukin 6 receptor: advanced therapeutic options in inflammation. Clin Pharmacol Ther. 2017;102:591–8. https://doi.org/10.1002/cpt.782.
Article CAS PubMed Google Scholar
Saevarsdottir S, Stefansdottir L, Sulem P, et al. Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset. Ann Rheum Dis. 2022;81(8):1085–95. https://doi.org/10.1136/annrheumdis-2021-221754.
Article CAS PubMed Google Scholar
Schwarzer G, Carpenter JR, Rücker G. Meta-Analysis with R. Cham: Springer International Publishing; 2015.
Shancui-Zheng J-Z, Guoyuan-Lu et al. (2022) Polymorphism in STAT4 Increase the Risk of Systemic Lupus Erythematosus: An Updated Meta-Analysis. Int J Rheumatol 2022:. https://doi.org/10.1155/2022/5565057
Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023–38.
Article CAS PubMed Google Scholar
Sohani ZN, Sarma S, Alyass A, et al. Empirical evaluation of the Q-Genie tool: A protocol for assessment of effectiveness. BMJ Open. 2016;6:1–7. https://doi.org/10.1136/bmjopen-2015-010403.
Tarakji I, Habbal W, Monem F. Association between STAT4 rs7574865 polymorphism and rheumatoid arthritis: debate unresolved. Open Rheumatol J. 2018;12:172–8. https://doi.org/10.2174/1874312901812010172.
Comments (0)